Bioengineered self-sealing synthetic arteriovenous graft for hemodialysis access

用于血液透析通路的生物工程自封闭合成动静脉移植物

• 批准号: 479454
• 负责人: Yim Evelyn K
• 金额: $ 79.14万
• 依托单位: University of Waterloo (Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-03-01 至 2028-03-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=479454&lang=en
• 关键词: Arteriovenous Graft; Biomaterials Nanofabrication; Early Cannulation; Endothelialization; Hemodialysis Access; Intimal Hyperplasia; Lumenal Modification; Self-Sealing Biomaterials; Vascular Biomechanics; Vascular Tissue Engineering

Chronic kidney disease (CKD) is one of the leading causes of death and disability worldwide. The number of people suffering from CKD is expanding rapidly. The majority of patients with kidney failure rely on hemodialysis for maintenance of life. A hemodia

慢性肾脏病（CKD）是全球死亡和残疾的主要原因之一。患有CKD的人数正在迅速增加。大多数肾衰竭患者依靠血液透析维持生命。A hemodia